![](/img/cover-not-exists.png)
Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Tanguy Seiwert,John Sarantopoulos,Howard Kallender…Volume:
31
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-012-9861-3
Date:
April, 2013
File:
PDF, 200 KB
english, 2013